Type 2 Diabetes Connect
  • Saved

752-P: LIVRQNac (AXA1125) Enhances Insulin Sensitivity in Primary Human Hepatocytes and in Subjects with NAFLD and T2D

752-P: LIVRQNac (AXA1125) Enhances Insulin Sensitivity in Primary Human Hepatocytes and in Subjects with NAFLD and T2D

Source : https://diabetes.diabetesjournals.org/content/70/Supplement_1/752-P

Background: AXA1125, an investigational composition of 5 amino acids and n-acetyl-cysteine, targets multiple biologies relevant to NAFLD pathogenesis. Methods: Primary human hepatocytes (PHH) from multiple donors were pretreated with AXA1125...

  • Saved

Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study - Cardiovascular Diabetology

Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study - Cardiovascular Diabetology

Source : https://cardiab.biomedcentral.com/articles/10.1186/s12933-021-01326-2

Background To examine the impact of weight change on incident cardiovascular disease and coronary heart disease (CVD/CHD) among an Iranian population with type 2 diabetes mellitus (T2DM). Methods The study...

  • 5yr
    . Further researches, especially clinical trials, are needed to examine the effect of intentional and unintentional weight change on common adverse outcomes among diabetic populations.
  • Saved

WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study

WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study

Source : https://onlinelibrary.wiley.com/doi/full/10.1002/ehf2.13513

Original Research Article Takanori Yasu , Corresponding Author Department of Cardiovascular Medicine and Nephrology, Dokkyo Medical University Nikko Medical Center, Nikko, Japan Correspondence to: Takanori Yasu, Department of Cardiovascular Medicine...

  • 5yr
    higher WBC count is a predictor of hospitalization for HF, all-cause death and AMI but not for stroke in patients with Type 2 diabetes mellitus and established CAD